Global Color Blindness Market - 2023-2030

Global Color Blindness Market - 2023-2030


Global color blindness market reached US$ XX billion in 2022 and is expected to reach US$ XX billion by 2030 growing with a CAGR of XX% during the forecast period 2023-2030.

The color blindness market is experiencing significant growth in recent years owing to its increasing prevalence. Color blindness is also known as color vision deficiency usually inherited through a genetic mutation. There is no prevention for color blindness but can manage by using different types of special glasses, contact lenses, and visual aids. The treatment is mainly based on the type of color blindness.

Color blindness usually happens when eye cones aren’t working properly. Cones have the ability to process light and images as they enter the eye and send signals to the brain that allow them to perceive color. According to the Cleveland Clinic organization, blue-yellow color deficiency affects 1 in 10,000 people, achromatopsia affects 1 in 30,000 people, and blue cone monochromacy affects 1 in 100,000 people.

Owing to the increasing prevalence of color blindness, rising awareness and early detection, increasing demand for color blindness glasses, increasing research and development activities, and technological advancements are the major factors expected to drive the global color blindness market over the forecast period.

Dynamics

Increasing Demand for Color Blindness Glasses Drive the Growth of the Color Blindness Market

There are significant advancements in technology and research activities, which led to the development of enhanced and well-designed color blindness glasses or color correcting glasses which provides more accurate color perception for the users. As the quality and effectiveness of color blind glasses improve, the demand for these color blindness glasses continuously increases.

For instance, on July 27, 2022, EyeMyEye, an eyewear platform introduces India’s first-ever range of Color Blind Glasses. These are usually crafted using the most advanced technology that enhances and improves color contrast and visual vibrancy for people suffering from Red-Green Color Blindness.

Color blindness glasses offer non-invasive solutions to many color blind individuals. The medical treatments may result in side effects and complications but these color blindness glasses can be easily used and removed according to the user. And there is also a wide availability of color blind glasses both online and offline, further driving the demand for color blind glasses.

Rising Awareness and Early Detection Also Drive the Growth of the Color Blindness Market

Awareness campaigns and awareness initiatives lead to increased education and identification of color blindness and these awareness programs also educate people about the availability of treatments. The date of color blindness awareness day is on September 06 every year, the day was chosen because of John Dalton's birthday, and he was the first person identified that color blindness existed.

For instance, on September 01, 2022, EnChroma, Inc., creators of glasses for color blindness announced the launch of International Color Blindness Awareness Month in September. EnChroma and over 50 museums, libraries, school districts, state and federal parks, universities, tourism agencies, and Lions and Kiwanis Clubs made social media posts and published other communications designed to educate their members, students, communities, and followers about Color Vision Deficiency (color blindness).

The awareness leads to early detection of color blindness and allows for timely intervention, which can be helpful for individuals with color blindness, especially in educational settings and where color recognition is critical. Early intervention involves using color blindness glasses, smartphone apps, contact lenses, or other assistive technological advancements to aid individuals in differentiating colors accurately.

Limited Treatment Options Will Hamper the Growth of the Market

Currently, there is no specific treatment for color blindness, this may impact the patients in facing challenges in daily life, but it can be managed by using special glasses, visual aids, and contact lenses. There are limited FDA-approved treatments available for color blindness management. While ongoing clinical trials and research efforts are still conducting for better management, the lack of effective therapeutic options for correcting color blindness has been a significant hampering factor in the market's growth.

The lack of the treatment options can lead to unmet patient needs, and individuals with color blindness seek alternative treatment options. The limited treatment options can also result in the reduced investments in innovative treatment options from pharmaceutical companies and researchers. This leads to an absence of FDA-approved medical treatment which discourages the companies from clinical trials and research activities, resulting in hampering the market share.

Segment Analysis

The global color blindness market is segmented based on type, treatment, end-user, and region.

The Red-Green Color Blindness From the Type Segment Accounted For Approximately 47.2% of the Color Blindness Market Share

The red-green color blindness is a common type of color blindness. In this type of color blindness, the cone cells are mainly responsible for recognizing the red and green colors that lack light-sensitive pigments, this is because they are not well-developed and do not function normally. The individuals who are affected by this type of color blindness find it challenging to pick out red and green colors in any given situation.

There are several sub-types of red-green color blindness, including protanopia, deuteranopia, protanomaly, and deuteranomaly. Red-green color blindness is usually more common in men compared to women. For instance, according to the colorblind awareness organization, color blindness (color vision deficiency) affects approximately 1 in 12 men (8%) and 1 in 200 women

This type of color blindness is because the genes for the color vision cone light-sensitive proteins are on the X chromosome, of which males have one and females have two. So, men are more common than women, due to one X in a male containing abnormal genes, color blindness will reveal itself, while females can compensate with the other normal gene on the second X chromosome.

For instance, on July 12, 2021, EnChroma, Inc., creators of glasses for color blindness announced the first safety glasses for the estimated 350 million people in the world who are color blind. The new line of EnChroma Safety Glasses is designed to help people with red-green color blindness overcome daily frustrations and obstacles in the workplace related to correctly identifying and interpreting colors.

Geographical Penetration

North America Accounted for Approximately 39.1% of the Market Share in 2022, Owing to the Increasing Prevalence and Strong Presence of Major Players

North America has a high prevalence of color blindness mainly due to their high population. Usually, color blindness affects a large portion of the global population, and North America is the most dominated region. For instance, according to the Iristech statistics, it is estimated that, in the United States, color blindness affects one in every 12 males and less than one in every 200 females.

North America region, especially the United States and Canada is home to major pharmaceutical companies, optical developers, and manufacturers specializing in healthcare including ophthalmology. This presence of major global players in the market ensures a wide range of color correcting glasses and other color aiding solutions for the management of color blindness, contributing to the dominance of the North America Region.

For instance, on August 01, 2023, RAZ Mobility, the leading provider of mobile assistive technology, announced the launch of the SmartVision 3. This Google-certified smartphone, manufactured by Kapsys, is designed specifically for individuals who are blind, color-blind, or visually impaired.

Competitive Landscape
The major global players in the color blindness market include Bausch and Lomb Corporation, Carelust Ltd, CooperVision, Inc., EnChroma, Inc., ColorLite GmbH, VINO Optics, Eyemyeye Pvt Ltd, Covisn, Pilestone Inc., and SportRx among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global color blindness market. During the pandemic, the healthcare systems were primarily focused on managing the COVID-19 cases, this inturn led to a shift in priorities and resources away from non-urgent medical conditions. As a result, the attention and investment in color blindness treatments and research might have been affected. The research activities and clinical trials on color blindness are also postponed due to the pandemic.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global color blindness market, owing to the low prevalence and absence of key market players in the region. However, the impact of the import and export of raw materials and color blind glasses, contact lenses is expected to have little influence over the global color blindness market growth over the forecast period.

By Type
• Red-Green Color Deficiency
Protanopia
Deuteranopia
Protanomaly
Deuteranomaly
• Blue-Yellow Color Deficiency
Tritanopia
Tritanomaly
• Complete Color Blindness (Monochromacy)
Blue Cone Monochromacy
Rod Monochromacy (Achromatopsia)

By Treatment
• Glasses And Contact Lenses
• Visual Aids

By End-User
• Hospitals
• Ophthalmic Clinics
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• On June 25, 2023, Samsung Electronics announced the addition of SeeColors mode on its 2023 TV and monitor lineup. The newly added accessibility feature provides various color settings based on degrees and types of color vision deficiency (CVD), offering an improved viewing experience.
• On June 13, 2023, Detroit River International Wildlife Refuge and EnChroma, creators of glasses for color blindness announced a collaboration to improve the experience for color-blind visitors to the Detroit River International Wildlife Refuge (DRIW). Guests who are red-green color blind can now use newly installed special SeeCoast viewer scopes, adapted with EnChroma lenses for color blindness, to enjoy nature in the Refuge in clear, vibrant color for the first time.
• On August 4, 2022, The Sumaira Foundation, a nonprofit organization focused on the rare neuroimmune diseases of NMOSD and MOGAD, is pleased to announce that it is joining forces with the Connor B. Judge Foundation (CBJF), a nonprofit started in 2014 to raise awareness and support research for NMOSD and other related autoimmune disorders. NMOSD stands for neuromyelitis optica spectrum disorder, a rare autoimmune neurological condition in which the immune system attacks cells in the central nervous system (CNS). Common symptoms include vision loss, color vision deficiency, paralysis, and others.

Why Purchase the Report?
• To visualize the global color blindness market segmentation based on type, treatment, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of color blindness market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global color blindness market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Treatment
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Demand for Color Blindness Glasses
4.1.1.2. Rising Awareness and Early Detection
4.1.2. Restraints
4.1.2.1. Limited Treatment Options
4.1.3. Opportunity
4.1.3.1. Technological Advancements
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Red-Green Color Deficiency *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Protanopia
7.2.4. Deuteranopia
7.2.5. Protanomaly
7.2.6. Deuteranomaly
7.3. Blue-Yellow Color Deficiency
7.3.1. Tritanopia
7.3.2. Tritanomaly
7.4. Complete Color Blindness (Monochromacy)
7.4.1. Blue Cone Monochromacy
7.4.2. Rod Monochromacy (Achromatopsia)
8. By Treatment
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
8.1.2. Market Attractiveness Index, By Treatment
8.2. Glasses And Contact Lenses *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Visual Aids
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ophthalmic Clinics
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Spain
10.3.6.5. Italy
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Bausch and Lomb Corporation *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Carelust Ltd
12.3. CooperVision, Inc.
12.4. EnChroma, Inc.
12.5. ColorLite GmbH
12.6. VINO Optics
12.7. Eyemyeye Pvt Ltd
12.8. Covisn
12.9. Pilestone Inc.
12.10. SportRx
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings